Yang, W J <br/><br/>
[Effectiveness of tyrosine kinase inhibitors against non-small cell lung cancer patients with postoperative recurrence harboring uncommon EGFR mutations].  [electronic resource] 

 -  Zhonghua zhong liu za zhi [Chinese journal of oncology]  Oct 2017 
 - 732-736 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0253-3766 
<br/><br/><label>Standard No.: </label>10.3760/cma.j.issn.0253-3766.2017.10.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Asian People<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>ErbB Receptors--genetics<br/>Exons<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mutagenesis, Insertional<br/>Mutation<br/>Neoplasm Recurrence, Local--drug therapy<br/>Point Mutation<br/>Postoperative Period<br/>Prognosis<br/>Protein Kinase Inhibitors--therapeutic use<br/>Retrospective Studies<br/>Time Factors